Sevita $1.275 billion notes offering
We advised the representative of the initial purchasers on the offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Terns Pharmaceuticals $747.5 million stock offering
We advised the underwriters on the public offering
Biocytogen RMB1.27 billion Shanghai IPO
We advised Biocytogen on its IPO and SSE listing
Denali Therapeutics $200 million stock and pre-funded warrants offering
We advised the representatives of the several underwriters on the offering
Immix Biopharma $100 million stock and pre-funded warrants offering
We advised the sole bookrunner and representative of the several underwriters on the offering
Mirum Pharmaceuticals $200 million private placement
We advised the placement agents on the transaction
Immatics $125 million follow-on offering
We advised Immatics on the offering
Merck $8 billion notes offering
We advised the underwriters on the notes offering
Aradigm $20 million Series A financing round
We advised Frist Cressey Ventures, which led the round
Illumina $500 million notes offering
We advised the underwriters on the offering